We are pleased to announce that the cutting-edge FcResolv® NOG portfolio has been recognized for its key applications in driving advancements in preclinical antibody-based drug discovery.

Discover how Taconic’s mouse models are revolutionizing metabolic dysfunction-associated liver disease (MASLD) research. Learn about their exceptional performance in mirroring human disease characteristics and their potential in developing new therapeutic interventions.